All Stories

  1. Optimization of Drugs Pharmacotherapy during Pregnancy Using Physiologically Based Pharmacokinetic Models - An Update
  2. Saliva versus Plasma Relative Bioavailability of Tolterodine in Humans: Validation of Class III Drugs of the Salivary Excretion Classification System
  3. Erratum to: Saliva Versus Plasma Bioequivalence of Rusovastatin in Humans: Validation of Class III Drugs of the Salivary Excretion Classification System
  4. Evidence of reduced oral bioavailability of paracetamol in rats following multiple ingestion of grapefruit juice
  5. Physiologically-Based IVIVC of Azithromycin
  6. Synthesis, In Vitro and In Vivo Evaluation of the N-ethoxycarbonylmorpholine Ester of Diclofenac as a Prodrug
  7. In Silico vs. In vivo Human Intestinal Permeability
  8. Saliva vs. Plasma Bioequivalence of Paracetamol in Humans: Validation of Class I Drugs of the Salivary Excretion Classification System
  9. Saliva vs. Plasma Bioequivalence of Metformin in Humans: Validation of Class II Drugs of the Salivary Excretion Classification System
  10. Interplay of biopharmaceutics, biopharmaceutics drug disposition and salivary excretion classification systems
  11. Bioequivalence of Two Pregabalin 300 mg capsules (Neurexal and Lyrica®) in Healthy Human Volunteers
  12. Therapeutic Drug Monitoring and Population Pharmacokinetics of Digoxin in Jordanian Patients
  13. The hydrolysis kinetics of monobasic and dibasic aminoalkyl esters of ketorolac
  14. Saliva versus Plasma Pharmacokinetics: Theory and Application of a Salivary Excretion Classification System
  15. Effect of Microgravity on the Pharmacokinetics of Ibuprofen in Humans
  16. Plasma concentrations of 25-hydroxyvitamin D among Jordanians: Effect of biological and habitual factors on vitamin D status
  17. Metformin IR versus XR Pharmacokinetics in Humans
  18. A retrospective, open-label analysis of the population pharmacokinetics of a single 10-mg dose of loratadine in healthy white Jordanian male volunteers
  19. EFFECT OF REPLICATE DESIGN ON DRUG VARIABILITY AND BIOEQUIVALENCE IN HUMANS
  20. EFFECT OF TRUNCATED AUC METHOD ON DRUG BIOEQUIVALENCE IN HUMANS: AN EMEA DRAFT GUIDELINE EVALUATION
  21. Pharmacokinetics and bioavailability of sulfadiazine and trimethoprim following intravenous, intramuscular and oral administration in ostriches (Struthio camelus)
  22. Comparative Pharmacokinetics of Gentamicin after Intravenous, Intramuscular, Subcutaneous and Oral Administration in Broiler Chickens
  23. Pharmacokinetics of Tilmicosin (Provitil Powder and Pulmotil Liquid AC) Oral Formulations in Chickens
  24. Pharmacokinetics and bioavailability of doxycycline in ostriches ( Struthio camelus ) at two different dose rates
  25. Bioequivalence evaluation of two brands of fluoxetine 20 mg capsules (Flutin and Prozac) in healthy human volunteers
  26. Comparative bioavailability of two brands of atenolol 100 mg tablets (Tensotin and Tenormin) in healthy human volunteers
  27. Bioequivalence assessment of Lovrak (Julphar, UAE) compared with Zovirax (Glaxo Wellcome, UK)-Two brands of Acyclovir-in healthy human volunteers
  28. Bioequivalence evaluation of two brands of aceclofenac 100mg tablets(Aceclofar and Bristaflam) in healthy human volunteers
  29. Bioequivalence evaluation of two brands of amoxicillin/clavulanic acid 250/125 mg combination tablets in healthy human volunteers: Use of replicate design approach
  30. Pharmacokinetics and bioequivalence evaluation of two simvastatin 40 mg tablets (Simvast &Zocor) in healthy human volunteers
  31. Bioequivalence evaluation of two brands of enalapril 20mg tablets (narapril andrenitec) in healthy human volunteers
  32. Bioequivalence evaluation of two brands of furosemide 40mg tablets (Salurin and Lasix) in healthy human volunteers
  33. Bioequivalence evaluation of two brands of metformin 500 mg tablets (Dialon®& Glucophage®) - in healthy human volunteers
  34. Bioequivalence evaluation of two brands of gliclazide 80 mg tablets (Glyzide®& Diamicron®) - in healthy human volunteers
  35. A Novel Approach to Increase Oral Drug Absorption
  36. Bioequivalence assessment of Azomycin� (Julphar, UAE) as compared to Zithromax� (Pfizer, USA)?two brands of azithromycin?in healthy human volunteers
  37. Enhancement of oral absorption of metronidazole suspension in humans
  38. Formulation and Release Behavior of Diclofenac Sodium in Compritol 888 Matrix Beads Encapsulated in Alginate
  39. Determination of the population pharmacokinetic parameters of sustained-release and enteric-coated oral formulations, and the suppository formulation of diclofenac sodium by simultaneous data fitting using NONMEM
  40. Determination of the population pharmacokinetic parameters of sustained‐release and enteric‐coated oral formulations, and the suppository formulation of diclofenac sodium by simultaneous data fitting using NONMEM